chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a medical assistant, refers to a currently 2 year old patient of unknown gender. No pertinent medical history, drug reactions/ allergies or concurrent conditions were reported. On an unknown date, the patient was vaccinated with an improperly stored VAQTA, (which had a lot # of N020686 and an expiration date of 22-OCT-2018; however, dosage number and route of administration were not reported), for prophylaxis. Nonetheless, no adverse effects were reported. The vaccine experienced the following temperature excursion since an unknown date: 49 F for 9 days. Reportedly, there had been no previous temperature excursions and the aforementioned ones were identified due to a data logger. Furthermore, no product quality complaint was involved. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1808USA007361: US-009507513-1808USA007362: US-009507513-1808USA007363: US-009507513-1808USA007364: US-009507513-1808USA007365: US-009507513-1808USA007366: US-009507513-1808USA007367: US-009507513-1808USA007368: US-009507513-1808USA007369: US-009507513-1808USA007370: US-009507513-1808USA007371: US-009507513-1808USA007372: US-009507513-1808USA007373: US-009507513-1808USA007374: US-009507513-1808USA007375: US-009507513-1808USA007376: US-009507513-1808USA006354.
SEVERE BODY ACHE; GIGGLES; HIGH ANXIETY; FEELING DRUNK; LOW GRADE FEVER; MILD AND DRY SORE THROAT; This spontaneous report received from a patient concerned a 48 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included allergic to some topical polyethylene glycol (peg), and hand injury. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 09-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included naproxen for hand injury. On 09-JUL-2021, the subject experienced mild and dry sore throat. On 09-JUL-2021, the subject experienced giggles. On 09-JUL-2021, the subject experienced high anxiety. On 09-JUL-2021, the subject experienced feeling drunk. On 09-JUL-2021, the subject experienced low grade fever. Laboratory data included: Body temperature (NR: not provided) 98.8. On 10-JUL-2021, the subject experienced severe body ache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from mild and dry sore throat, severe body ache, low grade fever, feeling drunk, giggles, and high anxiety. This report was non-serious.
Pt was here to received her 2nd dose of the Pfizer Vaccine. Immunization Technician accidently dispensed the Jassen covid Vaccine instead. We called patient and notify and was understanding . We notify them to monitor symptoms and side effects . Pt said she will not take the 2nd dose of the Pfizer .
mild hives/rash on upper chest and back, itchy; no rash on right arm where shot was given. Hives with itch appeared about 3 hours after the shot was given, along with an itchy feeling in mouth and on tongue and feeling of strangeness in throat. I felt mostly normal during the 30 minutes after the shot, but developed a headache, chills, mildly upset stomach. I have anxiety issues and was nervous about getting shot so was hesitant to label anything as a side effect as it could be anxiety/panic disorder etc. But the rash/hives are itchy - I showered which made them itchier. I'm submitting this @ 10:30pm EST, my shot was @ 2pm EST - I have taken more zyrtec worried I am having an allergic reaction. I am filing this because I am worried about the 2nd shot - I do not want to have  a worse allergic reaction after the 2nd shot. I will call my allergist. He manages my allergies and advised me to continue taking my seasonal allergy meds and zyrtec as normal during the shot today. Presently there are no hives/itch on any other parts of my body except my upper chest and upper back.
patient was so sick; Initial information received on 09-Nov-2020 regarding an unsolicited valid non-serious social media case from a consumer (patient) via Social media.  This case involved a patient with unknown demographics who was so sick (Illness), while he/she received INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient was so sick (Illness) (Unknown latency) following the administration of INFLUENZA VACCINE.  The patient was reported that he/she could not get off the floor, he/she had not had a shot since and had not had the flu.  Details of laboratory data not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown for the event, at the time of reporting.  There will be no information available on the batch number for this case.
This spontaneous report as received from a patient's mother, refers to a female patient of unknown age. The patient's concurrent conditions and medical history were not reported. On an unknown date (reported as 'when she was younger'), the patient was vaccinated with a dose of GARDASIL (dose, route, lot# and expiration date were not provided). It was reported, that since an unknown date, the patient was having unspecified problems and has needed biopsies, unspecified laboratory tests and pap smears. The outcome of unspecified problems was not reported. The relatedness between the event and GARDASIL was not provided. Additional information is not expected, because there are no reporter's contact details.
Pt vaccinated with DTP developed swollen arm, temp 101.2, no vomiting. Prescribed Tylenol.
Rash and itching on various body surfaces. 11 days after vaccine MMR vaccination. Seen 11/23/04,11/24/2004 and 12/01/2004
5/27/09 about 12:00 patient became weak, pale, collapsed to floor, febrile, tachycardia. Patient seen in ER, monitored, labs (CBC, BASIC chemistry and U/A) obtained. Monitored for 2 hours and 20 minutes . TYLENOL given.
Pzifer COVID 19 vaccine vial had white speck floater after dilution with NS 1.8 ml. Saw upon inspection and zero doses were utilized from this vial.
I could not go to sleep on Sunday night February 28th, after only a couple hours sleep I woke to watery eyes.  Symptoms progressed throughout the day.  I went to urgent care clinic on Tuesday, March 2nd and they sent me straight to ER and I was diagnosed with Bell's Palsy.  I cannot shut one eye, tingling of face, mouth, and tongue.  I was prescribed and antibiotic and steroid.
Patient died suddenly and unexpectedly on 2/21/2021 one week after receiving first vaccine on 2/20/2021.
This spontaneous report as received from a physician refers to one of 1 year old male twin infants. On an unknown date the patient was vaccinated with the first dose of VARIVAX (Merck) (Lot # not reported). On an unknown date both of the twin infants developed a raised area and local reaction rash at the injection site. The patient also had the rash over his legs and arms. The outcome was unknown. The patient sought medical attention through seeing the physician. This is one of two reports received from the same reporter. Additional information is not expected.
Flu symptoms; headache; muscle pain; sore throat; sinusitis; weakness/loss of energy; tiredness; Pfizer Bivalent - Dose Number: 1; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 27Oct2022 as dose 1, single (Batch/Lot number: unknown) at the age of 45 years for covid-19 immunisation. The patient didn't receive BNT162b2 (BNT162B2). The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: WRONG PRODUCT ADMINISTERED (non-serious) with onset 27Oct2022, outcome "unknown", described as "Pfizer Bivalent - Dose Number: 1"; INFLUENZA (non-serious) with onset 28Oct2022, outcome "unknown", described as "Flu symptoms"; HEADACHE (non-serious) with onset 28Oct2022, outcome "unknown"; MYALGIA (non-serious) with onset 28Oct2022, outcome "unknown", described as "muscle pain"; SINUSITIS (non-serious) with onset 28Oct2022, outcome "unknown"; OROPHARYNGEAL PAIN (non-serious) with onset 28Oct2022, outcome "unknown", described as "sore throat"; FATIGUE (non-serious) with onset 28Oct2022, outcome "unknown", described as "tiredness"; ASTHENIA (non-serious) with onset 28Oct2022, outcome "unknown", described as "weakness/loss of energy".  Additional information: There was no other vaccine in four weeks or Other medications in two weeks and there was no covid prior vaccination or covid tested post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever at night, aching arm at the location of injection, heavy sweating, headache (Tylenol taken at night to relieve symptoms).  In the morning body aches, fever 101.1, headache.  Arm pain at the location of the injection.
After both vaccine doses I experienced minor spotting for 1-2 days. It resolved itself on its own and pregnancy remains healthy at 13 weeks. I have not experienced vaginal spotting at any other time in this pregnancy or my previous pregnancy. My due date is 12/1/21,
Moderna Vaccine. No immediate reaction. 1/13/21 I noticed there was still a sizable lump at the injection site. Called our Employee Health hotline and they advised to apply heat and massage the area. 1/14/21, I applied heat and massaged the area and within a few hours the injection site started to get red and increase in size, and my eyes began to itch and swell. Took a Benadryl and in the morning there was more swelling in my face. Went to the dr, they couldn't confirm if was or wasn't vaccine related, and advised to continue taking Benadryl and apply cool compress if arm was painful. Swelling continued on 1/15 and 1/16. Arm still has a large spot, it is less red in color now, there is still slight heat at the injection site. I have been taking at least 1 Benadryl for the last 7 days now.
The patient was administered a dose drawn up from a vial that had been punctured approximately 19 hours prior, which is beyond the recommended 6 hour expiration once the vial is punctured. The vial had been maintained in the refrigerator once punctured.
recurrence/worsening of lymphoma; recurrence/worsening of lymphoma; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in 2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LYMPHOMA (medically significant), outcome "unknown", described as "recurrence/worsening of lymphoma". Clinical courses is as follows: The reporter heard a story anecdotally from brother who is a physician. He said a colleague was also suspicious of a link between recurrence/worsening of lymphoma (in himself) after mRNA vaccination. That was in spring of 2021 when were getting vaccinated. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
23 year old male developed a slight swelling that progresses to a large area of redness with blisters, swelling and itching on upper arm, 2 days after receiving a yellow fever vaccine, pt denied fever, SOB, chest or joint pain, nausea vomiting or headaches. He was treated with prednisone 10mg a day for 7 days, fexofenadine 180 mg a day and diphenhydramine 50mg PO at bedtime.
My first 2 periods after starting the injections where extremely heavy; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female patient (non-pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: ENG202) dose 1 via an unspecified route of administration in left arm on 25Feb2021 at 08:15 AM as single dose for COVID-19 immunization. Medical history was not reported. Concomitant medication included ascorbic acid, betacarotene, biotin, calcium pantothenate, calcium phosphate dibasic, chromium picolinate, colecalciferol, cupric oxide, cyanocobalamin, ferrous fumarate, folic acid, magnesium oxide, manganese amino acid chelate, nicotinamide, phytomenadione, potassium iodide, potassium sulfate, pyridoxine hydrochloride, retinol palmitate, riboflavin, selenomethionine, thiamine hydrochloride, tocopheryl acid succinate, zinc oxide (MULTI VITAMIN ONE A DAY) received in two weeks. No other vaccines received in four weeks. The patient previously took azithromycin (ZITHROMAX) and had allergies. Her first 2 periods after starting the injections where extremely heavy on 01Mar2021. She was not pregnant and not going through menopause as confirmed by her doctor. No treatment was received for AE. The outcome of event was unknown.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Oct2022 as dose 3 (booster), single (Lot number: GH9697) at the age of 53 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "depression" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.
Entered observation @ 1258.  Around 1322, voiced her "lips" felt swollen.  No swelling noticed when pt showed this nurse her lips.  Around 1328 voiced "tightness in throat".  Benadryl 25mg given.  Around 1340, voiced Benadryl did alleviate s/s.  Voiced no s/s of any other distress nor trouble breathing.  Left observation @ 1344.
Felt disconnected and dizzy immediately after shot. Within 15 minutes max. labored breathing. Reported to nurse. She gave me 2 chlortimaton, no affect, gave 2 more, still no affect. Within 30 minutes of shot throat was almost completely closed and I was white, erratic blood pressure and heart rate, delirious, they gave me shot of .3 epinephrine and I could then breathe.  Ems came and stabilized me.  Went to ER where they watched me for a few hours. Released that night. Had to take almost a week off work to recover. Have had 2 follow-ups with primary md and 1 with Workcare since  this happened on my job site.  12/4/08 ER note received for DOS 10/29/08 with DX: Reaction to flu shot. Pt presented to ER following episode of lightheadedness, dizziness, SOB, feeling unwell and feeling like throat was closing up.  BP high for pt 130/80s.  Received epi with improvement noted.  PE WNL. D/C to f/u with PCP.
Severe hives began 12 days after 2nd dose, followed by swelling and joint pain.  Went to urgent care in day 4 and began taking Hydroxyz 25 mg every 8 hours for 4 days. Began subsiding after a couple of days on meds. Still itchy and some joint pain, but better. Meds made me too sleepy for long term use. Hoping they go away on their own. Using topical anti itching lotions now
Herpes zoster-appearing skin rash localized to deltoid area on opposite arm (vaccination in left arm, skin rash on right arm in same dermatome).  Symptoms included itch and mild localized pain with no apparent systemic symptoms.   Rash was a cluster of 4-5 elevated  erythematous 1mm lesions with mild surrounding erythema.  Lesions blistered during the course of a few days.  After almost 4 weeks post-injection the blisters slowly resolved, leaving a red mark at each site.
pain and tenderness over the thyroid; left axillary adenopathy/lymphadenopathy; significant thyroiditis; neck pain; fatigue; palpitations; This is a spontaneous report from a contactable physician and a pharmacist. A 41-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246), intramuscular, administered in arm left on 10Jan2021 13:00 as a single dose (at the age of 41-years-old) for covid-19 immunization. The vaccine was administered at the hospital. The patient had no known allergies and no other medical history (reported as none). The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140), administered in arm left on 20Dec2020 1:00 PM (at the age of 41-years-old) for covid-19 immunization. On 14Jan2021, the patient developed left axillary adenopathy which then subsided and developed left cervical lymphadenopathy and significant thyroiditis. The patient also experienced neck pain, fatigue and palpitations on 14Jan2021. On 15Jan2021, she had severe pain and tenderness over the thyroid. The reported events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient received prednisone, propranolol, Tylenol, antibiotics as treatment for the events. The patient underwent lab tests and procedures included SARS-CoV-2 test both via PCR and Nasal Swab: negative on Jan2021, 17Jan2021 and 24Jan2021. The outcome of lymphadenopathy, thyroiditis, pain and tenderness over the thyroid was recovering and unknown for the rest of the events.
Breakthrough case. Patient tested positive while receiving treatment for multiple falls. Expired 04-14-2021, Traumatic subdural hemorrhage with loss of consciousness of unspecified duration.
1 week and 1 day after vaccine patient had itching and burning on the hands, feet and knees
After receiving vaccine, patient broke out in shingles as confirmed by his provider on 07/19/21/  A course of valacylovir 1gm, doing 1 tid was dispensed for a 7 day supply.
Patient presented to ED on 9/13/21 with fever and cough, found to be covid positive with concern for overlying CAP +/- pulmonary pneumonia. Patient was treated appropriately and was recovering from covid 19 pneumonia when she became somnolent, developed acute hypoxemic respiratory failure and then cardiopulmonary arrest. The precipitating cause of her somnolence and respiratory failure are unknown. Patient was deceased on 9/26/21
For two days, I had a 101 fever, chills, nausea, sinus headache, muscle aches, and was sore at injection site. Now four days later I am mostly better but still suffering from weak muscles.
I do not see well at all; Lost my sense of taste and smell; Those were the symptoms of the virus; Lost my sense of taste and smell; Those were the symptoms of the virus; Worried; This is a spontaneous report from a contactable consumer. A patient of unspecified gender and age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 15Jan2021 at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced lost sense of taste and smell. Patient worried that those were the symptoms of the virus; do not see well at all. Patient also stated that not see well at all in Jan2021. Outcome of events was unknown.   Information on the lot/batch number has been requested.
This spontaneous report as received from a licensed practical nurse refers to multiple patients of an unknown age and gender. No information regarding the patient's concurrent conditions and medical history was provided. On an unknown dates, the patients were vaccinated with an unspecified number of doses of improperly stored PROQUAD, lot# 1033696 and expiration date: 28-FEB-2017 or lot# 1030591 and expiration date: 10-OCT-2017 or lot# 1024122 and expiration date: 30-DEC-2016 (dose and route of administration were not reported). The patients' concomitant therapies were not reported. There was no adverse effects reported. Product quality complaint was not involved. Additional information has been requested.
This spontaneous report as received from a physician refers to a patient around 80 years old. The patient was vaccinated with a 0.65 ml dose of live ZOSTAVAX in approximately January 2012 (about a year ago). No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient developed shingles. The patient had office visit for medical attention. The outcome of shingles was unknown. Additional information has been requested.
About 12 hours after the injection (around 10:30 PM Friday 3/39) I had chills for 3 hours, plus fever, aches, pains, nausea, headache, general malaise until  approximately 6 PM Saturday 3/30.
No additional AEs; expired PROQUAD was administered to a patient; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 03-MAY-202,1 the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) 0.5 ml injection, lot # S030093, expiration date: 24-MAR-2021 (strength and frequency were not reported) for prophylaxis. No additional adverse event was reported.
Pt. received vaccine in AM. Reported feeling  'tired' and 'having trouble breathing'.  Brought to ED by ambulance @ 1805hrs.. Per ED report, had mild tachypnea upon initial evaluation, HR 80, RR26, B/P 137/105, O2 sat 99% on room air.
3 days after vaccination patient in pharmacy arm where vaccine given was red, some itching, warm. The red arm was approx 6" in length and 3" wide oval shaped. Patient took BENADRYL and applied ice pack. BENADRYL helped with itching. 4th day area seemed to spread under arm and sore.
covid vaccine cause you to have hot flashes; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of HOT FLUSH (covid vaccine cause you to have hot flashes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HOT FLUSH (covid vaccine cause you to have hot flashes). At the time of the report, HOT FLUSH (covid vaccine cause you to have hot flashes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported  No treatment drugs were reported